Submitted by kzahs_258301 on Tue, 05/22/2018 - 6:32pm NCT02240693 BI 409306 United States Thursday, January 15, 2015 – Monday, September 18, 2017 128 128 Phase 2 Alzheimer's Disease Monday, September 18, 2017 Boehringer Ingelheim Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by kzahs_258301 on
Submitted by kzahs_258301 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.